Search RTI in the Media
Nextreme Thermal Solutions of Durham, NC, USA, which designs and manufactures microscale thin-film thermal management and power generation modules and sub-systems, says that its thin-film thermoelectric technology has achieved a 60.1°C temperature di
Every week, I see 12-year-olds who weigh 300 pounds or more, West Virginia University pediatrician Dr. Pamela Murray said.
The number of homegrown terrorism plots hatched by Muslim-Americans has declined over the last three years and remain relatively rare despite public fears, according to a study by a University of North Carolina, Chapel Hill sociology professor.
A new study released today (Feb. 8) by the Triangle Center on Terrorism and Homeland Security documents that concerns of counterterrorism officials about a potential wave of homegrown violent extremism have not materialized over the past two years.
No significant differences are found in efficacy comparisons of second-generation antidepressants, though physicians should consider varying frequency of side effects when developing treatment plans.
Couples who are married or living together will probably have more trouble parenting as a team if they have been violent toward one another during pregnancy, according to a team of psychologists.
After educating and putting forensic scientists into the field, a Duquesne University program is working to bring emerging technologies to those scientists.
This is going to sound like just another old guy rant, I'm afraid. But it's not. Or at least that's not all it is: I propose that people stop wearing headphones when they are out in public.
RTI International is proposing a high-risk, but high-reward, strategy the organization believes would help prevent the onset of diabetes, one of the biggest drivers of increased health care costs.
Germany’s tough reimbursement rules cause drug companies to consider alternative drug trial solutions
Pharma companies looking to introduce new products in Germany are grappling with how to design to drug trials that highlight patient benefit outcomes, EU drug consultants told BioPharm Insight.